Federal Register / Vol. 72, No.
40 / Thursday, March 1, 2007 / Notices
The seminar helps to implement the
objectives of section 903 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
393) and the FDA Plan for Statutory
Compliance, which includes working
more closely with stakeholders and
ensuring access to needed scientific and
technical expertise. The seminar also
furthers the goals of the Small Business
Regulatory Enforcement Fairness Act
(Public Law 104–121) by providing
outreach activities by Government
agencies directed at small businesses.
The following topics, as well as
others, will be discussed at the seminar:
• Doing business in a regulated
industry;
• Organizational structure of FDA;
• Overview of the quality system
regulation;
• Design controls;
• Documents, records, and change
control;
• Purchasing controls and acceptance
activities;
• Production and process control;
• Corrective and preventive actions;
• Complaints, medical device reports,
corrections, and recalls;
• Compliance issues;
• Management responsibility;
• Interacting with FDA—Where do
you go for assistance?
• General question and answer
session;
• Manufacturers and suppliers—the
chain regulatory responsibility;
• Reimbursement of medical
technology;
• The AdvaMed code of ethics; and
• Fraud and abuse.
Dated: February 23, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–3619 Filed 2–28–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
rmajette on PROD1PC67 with NOTICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
VerDate Aug<31>2005 15:01 Feb 28, 2007 Jkt 211001
9343
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, and/or contract proposals,
the disclosure of which constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, ‘‘Early
Diagnosis Using Nanotechnology-Based
Imaging & Sensing’’ and ‘‘Multifunctional
Therapeutics ‘‘Based on Nanotechnology’’.
Date: March 14, 2007.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Marriott Bethesda, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Joyce C. Pegues, PhD.,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 7149,
Bethesda, MD 20892, 301/594–1286,
peguesj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Community Networks Program.
Date: March 22–23, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Bratin K. Saha, PhD.,
Scientific Review Administrator, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8041,
Bethesda, MD 20892, (301) 402–0371.
sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Prevention,
Control and Population Science SEP.
Date: March 28, 2007.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Conference Room 210,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Jeannette F. Korczak, PhD.,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8115, Bethesda, MD 20892, 301–496–9767.
korczakj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\01MRN1.SGM
Dated: February 21, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–923 Filed 2–28–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders,
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, Blueprint
K18—Neurodegeneration.
Date: March 16, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Christine A. Livingston,
PhD, Scientific Review Administrator,
Division of Extramural Activities, National
Institutes of Health/NIDCD, 6120 Executive
Blvd.—MSC 7180, Bethesda, MD 20892,
(301) 496–8683, livingsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health,
HHS).
Dated: February 21, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–924 Filed 2–28–07; 8:45 am]
BILLING CODE 4140–01–M
01MRN1